share_log

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga ·  Mar 20 17:34

Gainers

  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares moved upwards by 13.9% to $2.71 during Wednesday's after-market session. The market value of their outstanding shares is at $14.7 million.
  • Leap Therapeutics (NASDAQ:LPTX) shares rose 11.21% to $2.84. The market value of their outstanding shares is at $72.6 million. As per the press release, Q4 earnings came out 2 days ago.
  • Jaguar Health (NASDAQ:JAGX) stock rose 10.94% to $0.09. The company's market cap stands at $18.2 million.
  • Sharps Technology (NASDAQ:STSS) shares moved upwards by 9.73% to $0.37. The market value of their outstanding shares is at $5.6 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) shares rose 8.88% to $1.96. The company's market cap stands at $7.1 million.
  • Iterum Therapeutics (NASDAQ:ITRM) shares rose 7.59% to $1.7. The company's market cap stands at $22.8 million.

Losers

  • Biophytis (NASDAQ:BPTS) shares decreased by 20.8% to $0.36 during Wednesday's after-market session. The market value of their outstanding shares is at $4.0 million.
  • Fresh2 Group (NASDAQ:FRES) shares declined by 16.63% to $0.62. The market value of their outstanding shares is at $14.6 million.
  • Etao International Co (NASDAQ:ETAO) shares decreased by 14.01% to $0.23. The market value of their outstanding shares is at $23.7 million.
  • Avinger (NASDAQ:AVGR) shares declined by 12.13% to $2.9. The company's market cap stands at $3.9 million. As per the news, the Q4 earnings report came out today.
  • Applied DNA Sciences (NASDAQ:APDN) shares decreased by 5.81% to $0.47. The company's market cap stands at $7.9 million.
  • Nexalin Technology (NASDAQ:NXL) stock decreased by 5.38% to $0.44. The market value of their outstanding shares is at $3.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment